Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
GLOBAL SARCOMA THERAPY NOW APPROVED FOR NEW ZEALAND PATIENTS 2023-02-17 03:00
111, Inc. Hosts Hua Medicine Launches First Official Flagship Store 2023-02-16 13:33
Randomized Controlled Trial Backs Clinical Efficacy of Lunit AI for Chest X-Ray 2023-02-13 21:00
B dot Medical to Install Ultra-compact Proton Therapy System at Thammasat University in Thailand 2023-02-13 14:00
HanAll Biopharma Invests in Interon to Seek Collaboration Opportunities 2023-02-10 20:00
Nona Biosciences Enters into HCAb Based Antibody Discovery Collaboration Agreement with Mythic Therapeutics 2023-02-10 13:00
US based COBRA diagnostic prostate cancer trial reaches recruitment target 2023-02-09 22:03
First Prescription for COSELA® (trilaciclib) Issued in China 2023-02-09 21:00
Technoderma Medicines Initiates TDM-180935 Atopic Dermatitis Clinical Program with Phase 1 Dose Escalation Trial 2023-02-09 21:00
AnPac Bio-Medical Science Enters into Definitive Agreement to Acquire Fresh2 Ecommerce Inc, a B2B Asian Food E-commerce Platform 2023-02-09 21:00
GC Biopharma Receives WHO Pre-Qualification for Filling and Finish Plant in Ochang, South Korea 2023-02-09 09:21
ImmVira Clinical Snapshot: Intratumoral Injected OV (MVR-T3011 IT) Monotherapy Achieved Median PFS of 12.9 Months on Treatment of Melanoma 2023-02-09 08:00
ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics Based on ReviR's Comprehensive Approach to RNA-targeted Technologies 2023-02-08 22:00
Meihua International Medical Technologies Co. Explores Application of ChatGPT Technologies to Develop Online AI Health Consultation Services 2023-02-08 20:30
Infectious disease specialist Dr. Regis A. Vilchez is appointed CMO of MicuRx Pharmaceuticals, Inc. 2023-02-08 16:05
Hinova Receives FDA Proceed Authorization for its IND Application for HP518, an Orally Bioavailable Chimeric Degrader Targeting Androgen Receptor for Prostate Cancer Treatment 2023-02-06 21:10
Inmagene receives IND clearance for IMG-008, a long-acting IL-36R mAb 2023-02-06 18:00
Ground-breaking results in Phase 2 scleroderma study by Certa Therapeutics demonstrates improvement in more than 60% of patients 2023-02-06 13:01
Daewoong Pharmaceutical begins the first administration of the Bersiporocin, new treatment for idiopathic pulmonary fibrosis, as Phase II clinical trial 2023-02-06 13:00
Briggs wins "National Manufacturing Award 2022" at Make UK, UK's leading Manufacturer's Organization 2023-02-03 13:54
1 39 40 41 42 43 146